Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

Basilea (Group)

Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have preclinical and clinical anti-infective assets in our portfolio. Basilea is listed on the SIX Swiss Exchange (SIX: BSLN). *

 

Period Start 2000-10-01 established (s-off)
  Predecessor Roche (Group)
Products Industry antibiotic
  Industry 2 dermatic
Persons Person Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board)
  Person 2 Blatter, Joachim (Basilea 201201– CFO before Swissmetal Industries)
     
Region Region Allschwil BL
  Country Switzerland
  Street 167b Hegenheimermattweg
  City 4123 Allschwil BL
  Tel +41-61-606-1111
    Address record changed: 2024-04-07
     
Basic data Employees D: 101 to 500 (2021-12-31)
  Currency CHF
  Annual sales 148,122,000 (revenue, total, consolidated (2021) 2021-12-31)
  Profit -6,831,000 (2021-12-31)
  Cash 148,700,000 (2021-12-31)
     
    * Document for »About Section«: Basilea Pharmaceutica Ltd.. (4/4/24). "Press Release: Basilea Announces US FDA Approval of Antibiotic Zevtara (ceftobiprole medocaril) for Three Indications". Allschwil.
     
   
Record changed: 2024-04-07

Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

More documents for Basilea (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top